Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Computer program aims to boost social skills in Huntington's patients

NCT ID NCT06828471

Symptom relief Sponsor: Rush University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a computer-based training program can help people with Huntington's disease better understand others' emotions and social cues. Twenty participants will use the program at home and come in for follow-up visits. The goal is to see if this approach is practical and liked by participants, before planning a larger study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Individual with Huntington's Disease * Diagnosed with Huntington's Disease based on genetic testing * Must be between 18 and 65 years of age * Native English speaker who is literate in English * Stable psychotropic medication regimen for 4 weeks * Must have a score of "somewhat easily" on all items in the CPQ-12 * MOCA \>18 * Completed 12 years of schooling * Access to laptop or mobile device * Willingness to come in person 6-12 weeks after first visit Inclusion Criteria for Caregiver of Individual with Huntington's Disease * Lives with patient * Must be between 18 and 65 years of age * Native English speaker who is literate in English * MOCA \>26 * Willingness to come in person within 6-12 weeks after first visit Exclusion Criteria for Individual with Huntington's Disease * Any known neurological condition (other than Huntington's Disease). * History of learning and/or intellectual disabilities * Currently actively involved in any other interventional trial (i.e. have begun the intervention) or within 4 weeks of completing the final assessments of an interventional trial. * Currently regularly completing a computerized cognitive training intervention. * Active suicidal ideation with some intent Exclusion Criteria for Caregiver of Individual with Huntington's Disease * Inability to provide informed consent * Active suicidal ideation with some intent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Huntington'S disease (HD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Caregiver Burden Huntington disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Huntington'S disease (HD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rush University Medical Center

    RECRUITING

    Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.